RECURSION PHARMACEUTICALS IN shareholders Q3 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 193 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
ALBION FINANCIAL GROUP /UT 120$9180.00%
TD Waterhouse Canada Inc. 100$7170.00%
VICTORY CAPITAL MANAGEMENT INC 15,246$116,6320.00%
Smithfield Trust Co 1,099$80.00%
Cutler Group LLC / CA 100$00.00%
Cutler Group LLC / CA 1,600$00.00%
Cutler Group LLC / CA 100$00.00%
DEUTSCHE BANK AG\ 59,688$456,6130.00%
COMERICA BANK 266$2,0350.00%
Amundi 88,562$565,0260.00%
Invesco Ltd. 107,090$819,2390.00%
Janney Montgomery Scott LLC 15,270$1170.00%
TORONTO DOMINION BANK 148$1,1320.00%
JANUS HENDERSON GROUP PLC 62,506$478,4800.00%
Allspring Global Investments Holdings, LLC 10,123$77,4400.00%
TUCKER ASSET MANAGEMENT LLC 91$6960.00%
Lindbrook Capital, LLC 452$3,4580.00%
Cresset Asset Management, LLC 15,077$115,3390.00%
Global Retirement Partners, LLC 300$2,1480.00%
D. E. Shaw & Co., Inc. 23,707$181,3590.00%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q3 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.